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O&&w. We soogbt to evaluate the ellectr of combioed 
admit~ietrntlot~ of inftn-low dose dipyridomoie end low dose 
dobutondne on unsessment of myoeardlal viability. 
lfac@9d.Ipardose str+3m eebocurd~y 
Mb either dobotundoe or dime isfbsion has beeo pm- 
pled for the tvcognitbM of myocnrdiai vinbiiity. 
IMsrhods. Tbirty4oor potieeta with m3t wnii motion dye- 
by hvoditnearionul eebocmdwy and with anglogrspbically 
pmvod comnrry artery disease underwent in co&notion with 
ttlwdlmenti ednlcnrdiogrupidc aoaitingt 1) low dose (5 to 
IO pg& per 0th over 3 q in) dobotomiee btfitsioq 2) isfro-low 
dam (0.28 n@g over 4 min) dlpyridomole ~sion; 3) combino- 
t&m of iafrn-low dose dipyvidnmok iofbsion immediately followed 
by low doee dobutnmine irfusion (combined dipyridrrmoie- 
dobutamine). 
&auk. Foliow~up rest echocordiogrnphy wan aveilshle lo 30 
petknt$. After revawolsrization, 82 scpmeals showed 8 conttuc- 
--__ .-.--.--___ 
The idcntificaGon of viable myocardium has been recognized 
as nn increasingly important goal in clinical cardiology (L-3). 
The pot&al reversibility of myocardial dysfunction in certain 
settings is now well established, but a remaining challenge is 
the development of an accurate means of reliably distinguish- 
ing reversible from irreversible dysfunction (4-7). Low dose 
dobutamine stress echocardiography is an attractive and in- 
creasingly used method of identifying viable myouerdium 
based on its ability 111 respond IO beta-adrcncrgic stimulation 
with an increase ir mytrardial thickening (H-14). The spcci- 
Rcily of low dose dobutamine stress echocardiography for 
prcdifting functional recovery is excellent, but its sensitivity is 
less than ideal. Thus, a segment that shows improved wall 
--- - 
tile improvement of 21 grade, whereas 63 segmettts remaioed 
uncbunged. Tbe sensitivity of dobntomine, dipyridnmole and 
cumbined dipyridamoiedobutomine for predict& recovery wae 
72% (05% cwnhhce Nesval ICI] Mt9lb to 81996), 67% (Ci SO% 
to 75%) and 94% (CI 86.3% to !YMb), respextlveiy. Tote epectfkity 
of dipyridemoie, dobutamine and combined dipyridamok- 
~rras954b(a~~to999s3,~b(ci~%to97~) 
and89%(cI7&4%095&~,rosacrtively..aealra~opthe 
~~~~~~~~~e 
teutwas80%+79%and92%+reqeddy(aunbloeddi~ 
dobntamiaevs.dobotamiso,pcOQ!kco&neddipyrklsmde- 
dobntlunine vs. dipyvim p < 0.01). 
Coocfu&nw. Infr&w &we dipytldmnoie edded to low dose 
dobotnmbte recruits nn ittot~~pic reserve in nsyneq#c sfqpnents 
that were tnmrespondera after either dobntomine or dipyridamole 
alone and destined to recwer after revamcnhrizat& 
motion with dobutamine. is hkely to be viable and to recover 
with revascularization; but viability is still possible even if wall 
motion does not improve with dobulamine. 
Experimental (15.16) and clinical (17.11) studies have 
shown that coronary vasodilator stress can recruit ai1 inotropic 
reserve in viable segments. In particular. the infra-low dipyr- 
idamoie dose regimen d&pates a dosage (0.28 m@g in 
4 min) that selectively explores myocardial viability and has 
virtua!!y no ischemic potential (18). This viability dose is called 
“infra-low” because it is 50% lower than the regular or low 
dose (0.56 mg!kg in 4 min), originally proposed by Gould (IY) 
and currently employed in perfuston imaging, ant! 67% lower 
thin the high dose (0.x4 mgntg in 10 min) most frequ’:ntly used 
for ochocardiographic imaging when myocardial iscbemio is 
the diayncntic end point (20.21). Ihercforc, in patients wirh 
chronic coronary artery d&as, a theoretically attractive way 
of increasing the sensilivity of pharmacologic stress echorardi- 
‘cqraph:, would bc the addition of infra-low dose dipyridamole 
~1 ktw dose dobutaminc. The two agents act through different, 
pc,f,antially synergic mechanisms: Dobutamine is a mild beta,- 
adrenoreceptor-mediated inotropic stimulus on the myo- 
caldium. secondarily incrc+tsing coronary flow (22). whereas 
diwidamolr i* an adenosine A,-receplor-mediated mild 
vasodilatnr stimulus on the coronary arterioics. secondarily 
increasing myocardial function (1516). The combined 
dipyridamole-dobutamine stress for viability should also be 
safe, because substantiaily higher doses of both dtpyrida- 
mole and dobutamine have been used in a single combined 
test for the diagnosis of coronary artery disease (23). with 
excellent accuracy and tolerability. 
We therefore separately performed infueians of low dose 
dobutamine alone, infra-low dose dipytidamok atone and 
combined Ma-low dose dipy&mole and tow dose dobut- 
amine in 34 consecutive patients nferred to the echoaudiog- 
raphy laboratory for assessment of myocardial viability. All 
patients underwent a revascularization procedure; echocardio- 
graphic follow-up after a successful revascularization was 
obtained in 30 patients. Our working hypothesis was that the 
combined infra-low dose dipyridamole and tow dose dobut- 
amine stress would have greater sensitivity in identifying 
myocardial viability than would stress with either d&r&mole 
or dobutamine alone. 
Metbds 
stady pattents. Fifty-one consecutive patients with a his- 
~oty of myocardial infarction, angiographically proved coro- 
nary artery disease, a technically satisfactory acoustic window 
and wall motion dymynergy of the left ventricle at rest were 
initially considered. Qf these 51 patients, 17 underwent the 
s.tress ecbocardiographic study but dii not enter the echocar- 
diographic follow-up program because they dim not undergo 
coronary revascularization on the basis of the independent 
decision of the referring physician. As in any other patient with 
coronary artery disease, this de&ii was based on clinical 
prasentation, coronary anatomy and evidence of inducible 
ischemia in addition to assessment of myocardial viability, 
which was not in itself an iodicstion for revascularization. 
Of the initial group of 51 patients, 34 (30 men and 4 women, 
age range 31 to 73 years [mean + SD 55 t 111) underwent 
revascularization and were enrolled in the study (Table 1). All 
34 patients had evidence of previous (>3 months) myccardial 
infarction. Twenty-two patients had a Q wave infarction and 12 
had a non-Q wave infarction. The site of the Q wave infarction 
was anterior in 12 patients and inferior in 10. Medical therapy 
was discontinued ~48 h before the stress echocardiographic 
examination in 111 patients; the other 16 patients were exam- 
ined while receiving antianginal therapy: nitrates in I patient 
beta-adrenqic blocking agents in 2 and combined therapy in 
13 (nitrates and calcium antagonists in 9, nitrates and beta- 
bltrken in 3 and triple therapy [rutrate #s calcium antagonist 
plus beta-blocker] in I). Coronary angiograpby demonstrated 
significant stenosis (Z%% diameter reduction by quantitative 
coronary angiography) of one vessel in 18 patients. of two 
vessels in 10 and of three vowels in 6. Average left ventricular 
ejection traction calculated from the apical four-chamber view 
by two-dimensiona! echocardiography (single-plane area- 
length method) was 43 t 12%. Coronary revawrtoriution was 
performed in all 34 patients either bk coronary artery bypam 
surgery (n = 9) or by percutaneous tramlmninal corooaq 
aagMplasty(n=25).Ofthe34patientJgubmittedto~- 
larization and entered in the follow-up program. 4 (Patients 31 
to 34) were ilubqw@ ezduded from folIow-up because 
~tionwas~.Qftheaefour 
ptkn&W0diediatheperiuperativeperiod,mehadearly 
restenosis(wlthtn1month)andonehadaperfoperattve 
reinfarctii comp&ted by ventricular gbrtlfation. A basethm. 
follow-up ecwam obtabmd at least 4 weeks (mean 7 t 
3) after revascularization was avaiMe in 30 patients. None of 
these patients showed clink& tmayma* el 
(ECQ)orechocardiogn@ccvidenceofaperioperattvemyo- 
eardial infarction, and all were thought to have had sume&aJ 
revascularization, because they were asymptomatkz and had 
fully negative results on functii tests of i&emia, induding 
muimalhighdosephannacologicstreasaehocerdiosraphy 
Barelk e4AmardiugmpMc exambtb Two-dimen- 
sionale&ocardiogramswereobtai&bymiingcommm&@ 
available imaging systems (Hewfett-Packard !3onos lfDO,lS60 
or 2CKlO or DSmtica 2.5 and 35MHz tmmducers). Echocar- 
diographicimageswerereco&donvHswdeompeforsub 
sequentp@backandanaly&Regionafwallmotionwas 
a!%Med~tothe -adationsoftheAnlerican 
Society of p (24) with a M-segment model. In 
all * segmental wag motion was semiqmmtitatfvely 
graded as foflowrc normal * 1; hypokineetic, marl& red&on 
of endomrdial motion and thickening = 2; skinet~ virtual 
ab&meofinwardnmtionandthi&ning=~anddyskioetiq 
pamdoGc wag motion away from the center of the left 
venlrickinsystole~4.AwallmotioaJcoreiadg~derived 
bydiiingthesumofindivkMsegmentscoresbythenumber 
of interpretable segments Bmeline eeboeardagnphy wss 
performed before ammaty an$op&y or cormmry artery 
2 surgery. lnadquately visualii segments were not 
w;nwdogkstreas . All patients un- 
detwent, in separate sessions and before coronary revamufar- 
b&on, low dose dobutamine infusion (5 &kg per mm 
followed by 10 &kg per min, each stage Ming 3 min); 
info&w dose d&r&mote (0.28 mg&g over 4 min); i&a-low 
dosedipyr&um&followedbylowdosedobutaminee&ocar- 
diiphy (Fig. 1). TM-dimensional echocardiogmms were 
continuously obmincd and intermittentfy recorded during drug 
administration. Ia the baseline studies as well as during stress, 
all standard echocardiogmphii views were obtained when 
possible. During the procedure, tbe bhnxl pressure and the 
ECQ were mcorded each minute. Og-line assessment of 
echocsrdiogmphic images was performed by two experienced 
independent investigators unaware of the clinical, angio- 
graphic and foltow-up data. When there was disagmemem 
between the two readers, which occurred in at least one 
segment in three patients, a third investigstor mviewed the 
imageswithoutkmMedgeofthepreviousamemmentanda 
ontsensus decision was achieved. Interobserver agreement 
tegarding the pmence or absence of myocardial viabibi in 4 
segment by segment amemmentwas92%.Thelowlevelof 
interobsemer varmbility between enptrienced obsemrs in our 
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laboratory has been dncumented (25) and i\ prohahly linked IO 
previous extcnsivc cxpcrience in joint reading and dcvclop 
ment oi a priori rc:rding criteria. thus overcoming the other. 
wise mom r4Wuttiat variability hetwscn indcp&tdcnt “ex- 
pert” rcadcrs (31). Digilal acquisition of images of imerest was 
ohtsinrd with a side by side display of rest and peak strcs$ 
images in a cinc-ltmp mode either on line or off line hy an 
arrayproecssor- based computer for medical image pnrcs+tg 
(Mipron, Kontron). A wall motion WIK index was derived for 
rest and peak stress echofardicrgrams (0 ts 1 min after ths end 
of cash infuskm),in all paticnth as previously described for the 
baseline echocardmgraphic cxaminatmn. A segment was cnn- 
sidcred tn skew signs of viahility when it improved by -z I grade 
at peak stress (for instame, a ftyp&inetic ‘&mcnt hecfrming 
normal or an akin&c segment becoming hypotinctic). 
1 21) Fxho. ECG. BP recordings 
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flJf&mtp. PDstoperatiYe rest wall mo- 
lion scm was determined by two experienced ectwcardio- 
@i#lWS WhD had IlO kIlOWkdf$ Of ltrcdls ti~@liC 
results. Digital acquisition of images was obtained with a side 
by side display of echocardiograms obtahmd at baseline (be- 
fore revascularization) and at follow-up (after revasc&ixa- 
don). Improved segmental wall motion at foibw-up was de- 
tined as endocardial excursion and wail thiclteoing (score 1 or 
2)inareasofakbtesiaordyGnesia(score3or4)atbaseline, 
or uormakation (score 1) of reduced et&cardiil excursion 
and wall thiekening (score 2) at baseline. 
8tstlaticol anafyafa. Values are expressed as mean value t 
SD. Differences in hemodynamic values before and after the 
infusions and in wag motion score index under different 
conditions were tested for signiftcance by analysii of variance 
and subgroup analysis by the Newman-Keuls test. Calculations 
of sensitivity, specigcity and accura9 were performed accord- 
ing to standard definitions and are reported with the corre- 
spunding 95% contidence interval (CT). Differences in thr 
sensitivity, specificity and accuracy of the different tests were 
evaluated with the chi-square test. A p value < 0.05 was 
considered statistically significant. 
Results 
The main clinical, echocardiiaphic and am&graphic 
features of the 34 study patients are reported in Table 1. 
BaseBue echocatxffogmphk fM&ngs. By inclusion criteria, 
all patients had a regtonal dyssynergy in the rest echocardio- 
gram. There were 168 segments with baseline dyssynergy: 
dyskinesia in 6, akinesia in 113 and marked hypokinesia in 79. 
Cllr~ical aod BcmodyAemir lodiw dutiag ptuwmwb& 
streaa. None of the 34 patients had significant side elects or 
showed echocardiognphic or ECC signs of ischemia aHer 
either dipyridamole or dobutamine infusion. However, in two 
patients a biphasic pattern (improvement of function followed 
by subsequent deterioration) and ECG changes were observed 
aHer the combined infra-low dose dipyridamole and low dose 
dobutamine stress. These two patients (Patientx 32 and 33) 
were not included in the final analysis because they were 
among the four who had no follow-up echocardiographic study 
as a result of unsuccessful revas4ulurixation. Tbc systemic 
hemodynamic tindings-blood pressure, heart rate-in base- 
line conditions and during the pharmacologic stress tests are 
shown in Table 2. In comparison with the baseline value, 
systolic blood pressure incrcascd slightly after dobutamine 
(p = NS) but dtd not change signiticantly after dipyridamule or 
dipyridamote-dobutamine. No test agected signiticaotly dia- 
stolic blood pressure Heart rate was also unchanged after 
dobutamine or dipytidamok alone. whereas a mild increase 
was obscrvcd after the combined difsyridamoledubutamine 
stress. 
Eeboeardiograpb& Badingr. Twenty-seven patients 
&wed impnwed vgmental wall motion during pham 
iugic stress testing, whereas in seven patients no contmctik 
rcFerve co& he identified. I;nonwement in wall motion 
Tat& 2 !baldpd chbnges During stless 
vie Testing - 
chmbhed 
Bt&neDoB DIP DIP-DOB 
occurred in the distnition of the vessel that was bypsa& or 
dilated, Wall motion score mdex was 1.48 2 0.25 at rest and it 
improved aignificantty after dobutamine (I .33 h 0.32 p < 0.05 
vs. rest), after diw ( I.34 + 0.32 p < tt.bS vs. rest, p - 
NS vs. dobutamine) rind after combined it&a-low dose dii 
idamole and low dose dobutamine sttem (1.29 ? 0.3, p < 0.05 
vs. rest, p = NS vs. dobutamine and vs. dipyridamole). 
Folbnv-up met Follow-up eehocardio- 
graphic examination after suazuful coronary revaacukuiaa- 
tion was available in 30 patirnts (Table 1). At baselbte 
echocardmgmphy at study entry, these 30 patients showed a 
total of I45 dyssyoergic segments Begional wall motion im- 
proved in time by ~1 grade in It2 segments (“viable”), whereas 
in the remaining 63 (“necrotic”) no improvement could be 
observed. Of the 82 Gable segmenta dobutambte and dii- 
amole correctly identitied 59 and 55 segments, respectively, 
whereas combined infra-low dose diidamok and tow dose 
dobutamine stress test identified 77. of the 63 necrotic seg- 
ment& ddnltaminc, dipyrhmk aud cxlmbined diplnidamole- 
dobutamine correctly identified 58, 60, and 56 segments, 
reqxctively. The sensitivity of dobutamine and dipyr@nole 
was 72% (Cl 60.9% to 81.3%) and 67% (CI SS.g%, to 7796, 
respecuvely, p = NS). However, with the bttroductior! of the 
combined methotl the sensitivity markedly improved to 94Yo 
(Cl 86.3% to 97.9%. p c 0.01 w. dobutaminc and vs. dipyrid- 
amole). The spe&city of dipyridmnok and dobuutmine was 
95% (Cl 86.7% to 99%) and 92% (82.4% to 97.3%) reapec 
tively and decnased to 89% (Cl 78.4% to 95.4%) for coin- 
bitted dipyridamole-dobutamine stress (p = NS). The aauracy 
of the dobutamine, diw and combined dipyridamde- 
dobutamine stress test in predicting the behavior of !hc basally 
dyssynergic myccardial segment after rcvascul~izrrtion was 
gO%, 79% ant! 92%, respectively (combined dip@amolc- 
dobutamine = p < 0.05 vs. dobutaminc and p < 901 vs. 
dipyridamole) (Fig 2). After revasculari~tion 22 patients had 
imptovcd segmental wall motion, and in 4 of these it was 
correctly predicted only by the combined dipyridamole- 
dobutiimine stress test. 
Discussion 
Our results arc in agreement with data f:om previous 
clinical studies (g-14) showing that vcntricuhu dysfunction of 
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acwracy of -f@% in prediig fun&xxi rtiovery after 
~arfiatiou. In addition, the present study ck:~WCrrjtrateS 
the feasibiity, tolerability and accuracy of a combined mfra- 
lowdosed@yr&moleandlowdosedobutamineregimcnfor 
sdective assesment of myoc&kd viability, as well as its 
superior aceomcy versns that either stress separately per- 
formed for prcd&ng fnn&nal recovery. This tinding Las 
potential pathfJphysi&gic and clinical relevanw. 
dabatamine. The raticnale of applying combiid infra-tow 
dose dipyridamcde and low dose dobutamine as an effeerzive 
st.imnhrs for myocardial viability recognition stems front two 
asumptions: 1) i&a-low dose dipyridamole is capable of 
recruiting contractile reserve in an asynergic but viable seg- 
ment; 2) i&e-low dose dipyridamole has an at least partially 
independent and additive effect to tow dose dobutamine in 
recruiting inctropic reserve in a basally dyssynergic region. 
lnfm-low a’ose d@yidanwie as a test for viability. In a dog 
model of shmned myocardium, Jeremy et at. (27) showed that 
a sigmticant improvement in percent systolic thickening in the 
stunned area was achieved with very low adenosine doses, and 
the same improvement was obtained with adenosine- doses np 
tc 100 times higher. Their observation might explain why the 
inotrcpic reserve can be recruited with a similar ethcacy by low 
and high doses of dipyridamole (17,lb) wbercas the ischemic 
effect increases sharply with increasing doses (21). 
h&a-low dose dipyridamole can recruit an inotropic re- 
serve through two possible mechanisms: hemodynamic (hnked 
to increased coronary flow) or metabolic (due to accumulation 
ofendogenousadellosine).DiWridamolemayincrwspcsti~b- 
emit function by increasing flow through the Gregg phenom- 
enon (28): Chaoges in vascular distension atiect sarcomere 
length and thereby intluencc contractiie function (29). This 
interpretation is consistent with experimental (3031) and 
clinical (32) studies demonstrating that a residual flow reserve 
can be elicited in the presence of a severe coronary stenosis 
and depressed baseline function. In ad&ton, stxlies using 
myocardial contrast echocardiography (33) and positron emis- 
sion tomography (34) have recently &wn that the presence of 
a rcsidnal coronary reserve after dipyridamole infusion iden- 
tifies segmental viability in pxre.1i.s with wag motion abnor- 
malities at rest. The second, probably more likely, mechanism 
does not need the increase in coronary gow as the reqgisiie of 
functional improvement. In an experimental study in a dog 
mcdel of stntmcd myocardium. Zughaii et al. (35) showed that 
the augmentation of endogcnous adenosine attenuates myo- 
cardial shmning independently of coronary flow or hemody- 
narniceffects.Thisconclusioniscorroboratedbythcstudyof 
Hy et rd. (36) who reported beneficial effects of adenosine on 
ischemia-reperfusioo injuty in isolated hearts at constant cor- 
onary tlow. Several tlow-independent benegcia! effects of 
edogenctts adencsine have been hypothesized (37) inch&g 
btockingofslowcakiumcharmels(withreductionofcytosolii 
accumul4ion of calcium), glycolysis stimulation z& inhiiition 
of generation of free radic&. 
Addiive&cfofcf@ydmkMd~f~ Nodii 
experimental data support the additive inotroptc action of 
dipyridamcle and dobutamine in viabtc scgmeats. Howcvcr, in 
themy, dipyridamole and dobutamine might have pent&y 
synergic actions because they act on different celhdar and 
molecula: targets: beta,-adrenoreccptor of rhe myocyte- for 
dobutamine, adenosinc A2 receptor of the coromq arteridar 
smooth muscle cell for dipyMamole. In addition, admin&a- 
tionofhighdosed@yr&m&doesnotblockthehemody- 
uamic responw and potentiates the tsehemic strength of hrgh 
dose dcbt~tamine (23). Furthcmmre, in a swine model of 
chronic reduction in perftisii pressure and Bow, Mi et al. 
(38) showed that at baselii, regional nryocardial blood Bow 
distaltothcstenosiswasreducedinbothendocanMand 
epicardial layers in comparison with levels in the normal zone. 
Transmural how increased a mean of 2K% from baseline in 
response to adenosine phrs phenylephrbm but only -50% in 
repme to adenosine alone. &cause the increase inflowis 
accompaniedbyanincreaseinfon&ninbothsttmncdand 
hibernating myocardium (6), the experimental data of Mills et 
al.mayprovideindinxtsupportforourempiricalftndingthat 
dipyridamoie and dobutamine have at least parti4y additive 
effects in eliiting a contractile respomx in viable myocardium. 
studytiaritatieas. onelimitationofourshtdyistheusecf 
e-chmdq&-wly documented improvement of wall mo 
tion at follow-up as the criterion for judging the accmaq of 
stress-induced ftmctiinal improvement We dii not use an 
independent standard such as guor~ucose or *&allium 
uptake. In addition, an ang+qbii control study was not 
performed at the tun: of follow-up examination. Some sek- 
meets that did not recover might have been perfused by 
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lmderestimatioa of tbe test’s Lspekwy for prekg Gability. 
Ihwtheless, the specifitity was exdlent for dobutamk, . . dlppkKkandCOOlbiIIedinfra-knvJosedi~~and 
IowdosedcA?M~w that this potential problem 
did not phy an important rde in the stody patients. In 
add&m, ail patients were asyqtomatic at foMowq aad bad 
lEgt3~resulpsOlI-lestsOfiSCheti(maxionahigh 
-pb armacol@c sfrem V)), suggebg per- 
sistingvesselpateucyinthese~n~ 
The ideaI phamw&+ 9trez.s for selective myocardial 
viability itssessmeut SbouId be hemodylmically neutral, with 
noeffectonheartrateoraystokbkmdpressure,becallse 
manipuIation of bemndynam~~ variabh can induce variations 
in call motkm aad th+keniq &epewentIy of the local 
inotmpk effect. In addition, the test should not induce isch- 
emia, as this may obscure the asxssmeot of fuxtional recov- 
ery. The comb&d i&a-low dose dipyridamd, and low dose 
dobutamine stress slightly deviate5 from this ideal profile, 
becauseitinducedasigSca@aItboaghmil~increasei 
bInodpressmeaadinducedixhemiaintwoparientswhobad 
tolerated well sparaMy adakistered infkors of dipyrida- 
moleanddobtmmine. 
The study group iaduded a substantial numkr of patients 
with only mikl left venthlar impairment (average ejection 
fracmn 43 i- 12%). With compktion of the present initial 
feasiiility study, the colnbiid ir&-a-iow dose dii 
and low dose dobutamine tea sbdd be assesstd hl patients 
with severe left ventrkdar dysfunctioq ia whom the di 
question qardhg the extent of viable t&e is more impor- 
tant.Ihisva&tioaiscurreatlyongoingcnamukicenter~ 
with the vID.4 (viiiwy Idert:ification with Lxpydamok- 
1 P!* 
is gnedy agreed that either 
stress-redistributitm-reinjection or rest-rediibution thallium 
protocols may provide cost-efIective intormation regarding 
myocadd viabay in the majority of patients with Chrofic 
ischemic left ventricubr dysfau&n (4). More recently, phar- 
macdogicstress~hasgaiaedkea5ingac- 
cqtmce, bxause of its losv a&, w&spread availability sod 
use of nonkmikg energy, in spite of the recognkd iimitatioa5 
of uluazound technokq of depending on patient’s acoustic 
window aad observer expertise (39). A more substantial limi- 
tationofstresechoGudiographyisthelessthanidealsenfi- 
tivity in predicting fuactional recovery after revasculariza- 
tion. The present study shoas that combined infra-low dose 
dipydamde-low dose dobutamine increases the dii 
racxmaq~flowdosecbhutaminestress~hy. 
providiq a CritisaI stepup in sensitivity, witbout loss in speci- 
ficity. with potential to make pbannaoologic strew eshoca& 
ogqhy even more at&a&F for detection oI rqcardial 
viabiiity. 
Asapotem4aikmitatioaoftbete5t.one.sbouIdcnmider 
thatdireudNgcus&pfepara~~aod~timeare 
abviow&~erritttFomburdiafrr-kwdosediWrjdaroole 
ad low dosd dobutandne than with either drng sqwateb 
used. However, wben compared with dobmamine alone, the 
imaging~eisincreasedbyonty4~(upt~ato~lisnagiog 
time of 10 q in). The prep;iath time in only trivia@ in- 
creased beca*use the same intraveaou Line is used for serial 
admiaktration of dipyr&7mole and dobutomk The incre- 
mental COSI of adtlmg the infra-Iow dose dipyridamok varier 
~~~al~iothe~~fouotries.InItaty,thedrug~~ 
2Omgofdipyr&mole(theaverageIowdtxeiaXNg 
person) is <Sl US. Altogether, the comb&d test seems to be 
a user-friemjly, mm-time-cnasum ing and cost-&c&e optioa 
toward an efkiint diagnosis of myocardial viability with 
pharmacologic stress echocardiography. 
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